Log In
Thursday 19th April 2018

New treatment for osteoporosis

22nd June 2010

The National Institute for Health and Clinical Excellence has released draft guidance which states that women with osteoporosis should be offered a new treatment called denosumab.

NICE said that post-menopausal women who did not respond to other treatments could be offered the drug. Dr Carole Longson, director of NICE's Health Technology Evaluation Centre, said: "Our independent appraisal committee felt that there was good-quality evidence to show that denosumab is a useful addition to the treatment options available to prevent a first fracture in women at increased risk and also at preventing further fractures in women who have already experienced one."


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: New treatment for osteoporosis
Author: Jess Laurence
Article Id: 15231
Date Added: 22nd Jun 2010


Arthritis Research UK

Recent Related Articles

Newcastle Hospitals appoints new chief executive

New online therapy tool for depression


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018